Maxim V. Sokolov

Maxim V. Sokolov

Auto-generated profile, based on publicly available information

Maxim V. Sokolov

Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in Neuron
Verified
Journal Article
Closed access
WAWilko D. Altrock
Wilko D. Altrock
SDSusanne Tom Dieck
Susanne Tom Dieck
MSMaxim Sokolov
Maxim Sokolov
AMAlexander C. Meyer
Alexander C. Meyer
ASAlbrecht Sigler
Albrecht Sigler
EGEckart D. Gundelfinger
Eckart D. Gundelfinger

9 January 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CHChristoph Heinze
Christoph Heinze
ASAnika Seniuk
Anika Seniuk
MSMaxim V. Sokolov
Maxim V. Sokolov
AHAntje K. Huebner
Antje K. Huebner
AKAgnieszka E. Klementowicz
Agnieszka E. Klementowicz
CHChristian A. Hübner
Christian A. Hübner
High blood pressure is the leading risk factor for death worldwide. One of the hallmarks is a rise of peripheral vascular resistance, which largely depends on arteriole tone. Ca2+-activated chloride currents (CaCCs) in vascular smooth muscle cells (VSMCs) are candidates for increasing vascular contractility. We analyzed the vascular tree and identified substantial CaCCs in VSMCs of the aorta and carotid arteries. CaCCs were small or absent in VSMCs of medium-sized vessels such as mesenteric arteries and larger retinal arterioles. In small vessels of the retina, brain, and skeletal muscle, where contractile intermediate cells or pericytes gradually replace VSMCs, CaCCs were particularly large. Targeted disruption of the calcium-activated chloride channel TMEM16A, also known as ANO1, in VSMCs, intermediate cells, and pericytes eliminated CaCCs in all vessels studied. Mice lacking vascular TMEM16A had lower systemic blood pressure and a decreased hypertensive response following vasoconstrictor treatment. There was no difference in contractility of medium-sized mesenteric arteries; however, responsiveness of the aorta and small retinal arterioles to the vasoconstriction-inducing drug U46619 was reduced. TMEM16A also was required for peripheral blood vessel contractility, as the response to U46619 was attenuated in isolated perfused hind limbs from mutant mice. Out data suggest that TMEM16A plays a general role in arteriolar and capillary blood flow and is a promising target for the treatment of hypertension.

1 December 1996 in Neuroscience
Verified
Journal Article
Closed access
AKA.M Kleschevnikov
A.M Kleschevnikov
MSM.V Sokolov
M.V Sokolov
UKU Kuhnt
U Kuhnt
Gavin Stewart DaweGavin Stewart Dawe
Gavin Stewart Dawe
JSJ.D Stephenson
J.D Stephenson
LVL.L Voronin
L.L Voronin

1 February 1995 in Brain Research
Verified
Journal Article
Closed access
MSMaxim V. Sokolov
Maxim V. Sokolov
AKAlexander M. Kleschevnikov
Alexander M. Kleschevnikov

1 August 2007 in Neuropharmacology
Verified
Journal Article
Closed access
MSMaxim V. Sokolov
Maxim V. Sokolov
OSOleg Shamotienko
Oleg Shamotienko
SDSorcha Ní Dhochartaigh
Sorcha Ní Dhochartaigh
JSJon T. Sack
Jon T. Sack
JDJ. Oliver Dolly
J. Oliver Dolly

Verified
Journal Article
Open access
PDF file
MKMuhammad Kamran Khalid
Muhammad Kamran Khalid
MAMuhammad Asad
Muhammad Asad
PHPetra Henrich-Noack
Petra Henrich-Noack
MSMaxim Sokolov
Maxim Sokolov
WHWerner Hintz
Werner Hintz
BSBernhard A. Sabel
Bernhard A. Sabel
Superparamagnetic iron oxide nanoparticles (SPIO-NPs) have great potential to be used in different pharmaceutical applications, due to their unique and versatile physical and chemical properties. The aim of this study was to quantify in vitro cytotoxicity of dextran 70,000-coated SPIO-NPs labelled/unlabelled with rhodamine 123, in C6 glioma cells and primary hippocampal neural cells. In addition, we analyzed the in vitro and in vivo cellular uptake of labelled SPIO-NPs. The nanoparticles, with average size of 10–50 nm and polydispersity index of 0.37, were synthesized using Massart’s co-precipitation method. The concentration-dependent cytotoxicity was quantified by using tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Intracellular localization of SPIO-NPs was detected by confocal laser microscopy. In vivo confocal neuroimaging (ICON) was performed on male Wistar rats after intravitreal injection followed by ex vivo retina whole mount analysis. When used for in vitro testing concentrations in the range of diagnostic and therapeutic dosages, SPIO-NPs proved to be non-cytotoxic on C6 glioma cells for up to 24 h incubation time. The hippocampal cell culture also did not show impaired viability at low doses after 24 h incubation. Our results indicate that our dextran-coated SPIO-NPs have the potential for in vivo drug delivery applications.